Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity
Top Cited Papers
- 1 January 2004
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 5 (1), 25-35
- https://doi.org/10.1016/s1535-6108(03)00332-5
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug‐resistant TCC in vitroInternational Journal of Cancer, 2002
- Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivoNature Medicine, 2002
- The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis inductionBlood, 2002
- Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patientsAnnals of Oncology, 2001
- Proliferation, cell cycle and apoptosis in cancerNature, 2001
- Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspasesThe EMBO Journal, 1999
- Death Receptors: Signaling and ModulationScience, 1998
- Proteases to die forGenes & Development, 1998
- IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspasesThe EMBO Journal, 1998
- X-linked IAP is a direct inhibitor of cell-death proteasesNature, 1997